Stryker (SYK) Net Cash Flow (2009 - 2026)
Stryker's (SYK) quarterly Net Cash Flow came in at $527.0 million in Q2 2026, up 2827.78% year-over-year from $18.0 million in Q2 2025, and up 147.31% quarter-over-quarter from -$1.1 billion in Q1 2026.
Analysis
Stryker (SYK) Net Cash Flow (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Net Cash Flow for 18 consecutive years, with $527.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Cash Flow rose 2827.78% year-over-year to $527.0 million in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 128.13% increase from a year earlier, with the FY2025 full-year figure at $291.0 million, down 59.41% from the prior year.
- Net Cash Flow was $527.0 million for Q2 2026 at Stryker, up from -$1.1 billion in the prior quarter.
- Over five years, Net Cash Flow peaked at $2.0 billion in Q3 2024 and troughed at -$1.5 billion in Q1 2022.
- A 5-year average of $29.3 million and a median of -$74.0 million in 2024 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow plunged 270.24% in 2024 and surged 2827.78% in 2026, its largest moves.
- Over 5 years, Net Cash Flow stood at $395.0 million in 2022, then jumped by 175.95% to $1.1 billion in 2023, then tumbled by 115.23% to -$166.0 million in 2024, then surged by 548.8% to $745.0 million in 2025, then declined by 29.26% to $527.0 million in 2026.
- The last three Net Cash Flow figures came in at $527.0 million (Q2 2026), -$1.1 billion (Q1 2026), and $745.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 746.50 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -169.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 527.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -892.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 458.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -8.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | -14.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 527.00 Mn |
| Mar 31, 2026 | -1.11 Bn |
| Dec 31, 2025 | 745.00 Mn |
| Sep 30, 2025 | 880.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | -1.35 Bn |
| Dec 31, 2024 | -166.00 Mn |
| Sep 30, 2024 | 1.96 Bn |
| Jun 30, 2024 | -450.00 Mn |
| Mar 31, 2024 | -622.00 Mn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 483.00 Mn |
| Jun 30, 2023 | -250.00 Mn |
| Mar 31, 2023 | -168.00 Mn |
| Dec 31, 2022 | 395.00 Mn |
| Sep 30, 2022 | 418.00 Mn |
| Jun 30, 2022 | -376.00 Mn |
| Mar 31, 2022 | -1.49 Bn |
| Dec 31, 2021 | 398.00 Mn |
| Sep 30, 2021 | 338.00 Mn |